SEASONAL VACCINATIONS

FLU SHOT, COVID-19 & RSV UPDATES

Vaccination Updates

This page will be updated regularly to display current inventory during respiratory season.

We do NOT HAVE FLU SHOTS OR COVID VACCINES as of September 14, 2026

  • BOOK HERE

    Regular flu shots 6months – 64 years OUT OF STOCK

    Regular 65+ flu shots OUT OF STOCK

    High dose 65+ flu shots OUT OF STOCK

  • For KMC patients and general public (12+ years of age) to book.

    BOOK HERE

    OUT OF STOCK until next covid booster becomes available late Fall 2026

    Covid Vaccine: PFIZER

  • ***RSV is publicly funded to all individuals aged 75 and older***

    75+ AREXVY® Vaccine: Available now, OUT OF STOCK
    BOOK HERE

    HIGH RISK 60-74, AREXVY® Vaccine: OUT OF STOCK
    BOOK HERE
    Eligibility Criteria:

    • lives in long term care/retirement residences

    • on hemo/ or peritoneal dialysis

    • patient with glomerulonephritis (GN) and is moderately-severely immunocompromised

    • organ/stem cell transplant recipients

    • patients experiencing homelessness

    • identify as First Nations, Inuit, or Metis

  • Beyfortus (weight 5kg+) IN STOCK
    BOOK HERE

    Beyfortus (weight under 5kg) Limited doses VERY LOW STOCK
    BOOK HERE

    Beyfortus® is publicly funded for administration in infants in the following groups:

    • Infants born before the RSV season (born on or after April 1, 2025 and younger than 8 months of age at time of administration).

    • Infants born during the season who did NOT receive Beyfortus in hospital.

    • Infants born outside of hospital settings.

    Children up to 24 months of age who remain vulnerable from severe RSV disease through their second RSV season, following discussion with a health care provider, including:

    • chronic lung disease of prematurity (CLD), including bronchopulmonary dysplasia/chronic lung disease

    • hemodynamically significant congenital heart disease (CHD)

    • severe immunodeficiency

    • Down syndrome/Trisomy 21

    • cystic fibrosis with respiratory involvement and/or growth delay neuromuscular disease

    • severe congenital airway anomalies impairing the clearing of respiratory secretions

  • RSV Vaccine (ABRYSVO®) for PREGNANT patients 32 to 36 weeks gestational age who will deliver during the RSV season. Only one RSV product is recommended for infant protection. NACI recommends BEYFORTUS® as the preferred option over maternal vaccination in pregnancy, except in specific cases (e.g., high-risk infants born to vaccinated mothers).

    BOOK HERE, or get during your next prenatal visit OUT OF STOCK